Oramed Pharmaceuticals Appoints New CEO and VP of Business Development
Oramed Pharmaceuticals Inc., a developer of oral drug delivery systems, today announced a key addition to its executive leadership team with the appointment of Joshua Hexter as Chief Operating Officer and Vice President of Business Development.
"Josh will be a great addition and complement to Oramed's executive team as we enter a new era in our clinical trials and activities," commented Oramed CEO Nadav Kidron.
Mr. Hexter brings to Oramed more than 15 years of prominent leadership with a commitment to excellence in the biotech industry in business development and operations. Most recently he was Executive Director of Corporate In-Licensing at BioLineRx. Mr. Hexter received his B.A. from the University of Wisconsin and his Masters in Business Management from Boston University.